CLDF Title
Home | Contact Us | Bookmark
Embassy of Education
Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences
  Release Date 01/18/2013
Expiration Date 01/18/2014
This program has expired. CME credit is no longer available.
  Robert Gish, MD
University of California, San Diego
San Diego, CA
Target Audience
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists and healthcare providers involved in the care of patients with chronic hepatitis C (CHC).
Goal Statement
The primary goal of this CME symposium is to better understand how to effectively target treatment for patients with hepatitis C (HCV) based on current guidelines and the latest clinical evidence.
Educational Objectives
After completing this activity, the participants should be better able to:
Describe current data on approved and experimental DAA’s used in combination with Pegylated Interferon and Ribavirin
Define the benefits and risks of treating now versus delaying therapy for different patient populations
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Chronic Liver Disease Foundation. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is an enduring material and consists of streaming audio and video. Successful completion is achieved by viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 0.25 hour(s).
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made: The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications. All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.


Be the first to know about our latest upcoming programs and events!


Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2024 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.